Venmax Drugs And Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 531015 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Venmax Drugs&Pharma

M-Cap below 100cr DeciZen not available

Venmax Drugs And Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
9.69
Market Cap:
2.2 Cr.
52-wk low:
4.2
52-wk high:
4.2

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Venmax Drugs&Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -33.2%-4.3%-7.3%-78.5%485%258.8%256.1%57.8%-352.2%-47.3%-
Value Creation
Index
-3.4-1.3-1.5NANANANANA-26.2-4.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.62.41.90.300.20.50.2000
Sales YoY Gr.-291.9%-20.6%-86.5%-100%NA213.3%-63.8%-100%NA-
Adj EPS -2.6-0.2-0.3-1.4-0.5-0.5-0.5-0.33.50.40.4
YoY Gr.-NANANANANANANANA-87.8%-
BVPS (₹) 0.80.60.4-3.6-4-4.5-5-5.3-1.8-1.4-3.7
Adj Net
Profit
-1.4-0.1-0.1-0.7-0.2-0.2-0.3-0.21.90.20
Cash Flow from Ops. 0.9-0.1-0.2-1.1-0.3-0.1-0.30.31.90-
Debt/CF from Ops. 1.7-14.9-9.2-1.8-8-47.1-98.80.2-113.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%NA-100%NA
Adj EPS NANANA-87.8%
BVPS-206.1%NANANA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-87.6-21.2-51.589.112.210.6116-99.1-27.3-17
Op. Profit
Mgn %
-69-4.7-7.1-237.60-157.8-53.9-198.200NAN
Net Profit
Mgn %
-222.6-3.3-7.1-287.30-156.8-57.9-96.800INF
Debt to
Equity
3.44.58.7-1-1-1-1-0.8-0.4-0.5-
Working Cap
Days
1,8122924301,3030339219539000
Cash Conv.
Cycle
172013930-85-55-729000

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Venmax Drugs And Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 0.4 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) -3.7 -
Reserves (₹ Cr.) -7 -
P/BV -1.13 -
PE 9.69 -
From the Market
52 Week Low / High (₹) 4.18 / 4.18
All Time Low / High (₹) 1.10 / 18.20
Market Cap (₹ Cr.) 2.2
Equity (₹ Cr.) 5.2
Face Value (₹) 10
Industry PE 48.8

Management X-Ray of Venmax Drugs&Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Venmax Drugs&Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0.622.431.930.2600.150.470.1700
Operating Expenses 1.042.542.070.870.230.390.730.500.130.19
Manufacturing Costs0.0300000.010.01000
Material Costs0.532.381.910.2400.090.320.2900
Employee Cost 0.250.040.040.060.050.100.220.060.010.03
Other Costs 0.230.120.120.570.180.190.180.140.120.16
Operating Profit -0.43-0.11-0.14-0.62-0.23-0.24-0.25-0.33-0.13-0.19
Operating Profit Margin (%) -69.0%-4.7%-7.1%-237.0%--157.0%-53.9%-198.0%--
Other Income 0000.120000.181.980.42
Interest 0.010000.0100000
Depreciation 0.0100000.010.010.010.010.01
Exceptional Items -1.3200-0.84000000
Profit Before Tax -1.77-0.12-0.14-1.34-0.24-0.24-0.27-0.161.850.23
Tax 0.52-0.0400000.01000
Profit After Tax -2.30-0.08-0.14-1.34-0.24-0.24-0.27-0.161.850.23
PAT Margin (%) -372.0%-3.3%-7.1%-515.0%--156.0%-57.9%-96.8%--
Adjusted EPS (₹)-4.4-0.2-0.3-2.6-0.5-0.5-0.5-0.33.50.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.420.340.20-1.87-2.11-2.35-2.62-2.79-0.94-0.71
Share Capital 5.245.245.245.245.245.245.245.245.245.24
Reserves -4.82-4.90-5.04-7.11-7.35-7.59-7.86-8.03-6.18-5.95
Minority Interest0000000000
Debt1.401.501.721.852.042.242.522.330.350.35
Long Term Debt1.401.501.720000000
Short Term Debt0001.852.042.242.522.330.350.35
Trade Payables0.111.640.570.080.060.310.400.460.470.33
Others Liabilities -0.67-0.64-0.740.080.090.130.160.300.330.25
Total Liabilities 1.252.841.750.140.070.330.460.310.210.21

Fixed Assets

Gross Block0.1700000.120.120.120.090.09
Accumulated Depreciation0.1700000.010.020.030.010.02
Net Fixed Assets000000.110.100.090.080.07
CWIP 0000000000
Investments 0.010.010.010000000
Inventories01.470000.110.22000
Trade Receivables0.210.140.680000.040.040.040.04
Cash Equivalents 000.0300000.0800
Others Assets1.031.221.030.140.070.110.100.110.100.10
Total Assets 1.252.841.750.140.070.330.460.310.210.21

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0.85-0.10-0.19-1.06-0.26-0.05-0.280.261.910
PBT -0.45-0.12-0.14-1.34-0.24-0.24-0.27-0.161.850.23
Adjustment 0.0300-0.09000.010.010.010.01
Changes in Working Capital 3.12-0.02-0.050.37-0.010.19-0.030.420.05-0.24
Tax Paid -0.520.0400000000
Cash Flow From Investing Activity 1.43000.010-0.110000
Capex 1.43000.010-0.120000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -2.280.100.221.020.260.160.28-0.19-1.980
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000.130.190.160.28000
Interest Paid -0.01000000000
Dividend Paid 0000000000
Others -2.270.100.220.890.0700-0.19-1.980
Net Cash Flow 000.03-0.030000.07-0.070
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-146.77-21.22-51.49N/AN/AN/AN/AN/AN/AN/A
ROCE (%)-42.9-6.29-7.34N/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio0.161.250.840.2700.751.20.4400
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/A1.030
Working Capital Days
Receivable Days762578005168100
Inventory Days0210000254124000
Payable Days176134211485073441053700

Venmax Drugs And Pharmaceuticals Ltd Stock News

Venmax Drugs And Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Venmax Drugs&Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Venmax Drugs&Pharma stood at ₹2.19.
The latest P/E ratio of Venmax Drugs&Pharma as of 01-Jan-1970 05:30 is 9.69.
The latest P/B ratio of Venmax Drugs&Pharma as of 01-Jan-1970 05:30 is -1.13.
The 52-week high of Venmax Drugs&Pharma is ₹4.18 and the 52-week low is ₹4.18.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Venmax Drugs&Pharma is ₹0.00 ( Cr.) .

About Venmax Drugs And Pharmaceuticals Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.